Prothrombotic states as risk factor of in vitro fertilization failures in women with infertility and psychosomatic disorders.
DOI:
https://doi.org/10.26641/2307-0404.2018.4.153000Keywords:
in vitro fertilization, psychosomatic disorders, antiphospholipid syndrome, hemostasis systemAbstract
Failures of in vitro fertilization (IVF) may be associated with prothrombotic states, the circulation of antiphospholipid antibodies (APA). 93 women with infertility were screened: 1 group - 32 women without severe psychosomatic disorders; 2 group - 61 women with psychosomatic disorders. The control group consisted of 30 fertile women. The level of AFA to membrane phospholipids (phosphatidylethanolamine, phosphatidylserine, cardiolipinum), antibodies to β2-glycoprotein (β2-GPI), hemostasis (platelet count, ADP-induced platelet aggregation index, fibrinogen concentration, prothrombin index, activated partial thromboplastin time - APTT, test for soluble fibrin-monomeric complexes, D-dimer), homocysteine in the blood serum was defined. The frequency of significant AFA titres in the group of women without psychosomatic disorders was 18.9%, and if they were present - 44.3%, the rate of β2-GPI 9.6% versus 24.5%, respectively. Only in 11.5% of women in 2 groups, elevated levels of APA were associated with β2-GPI and/or one or more clinical criteria for antiphospholipid syndrome (APS). In patients with infertility and psychosomatic disorders, increased platelet aggregation in the context of relative thrombocytopenia, higher fibrinogen levels, soluble fibrin-monomeric complexes, and prolonged APTT with elevated D-dimer levels was revealed. Some patients have hyperhomocysteinemia. Factors that adversely affect the efficiency of IVF in the patients with psychosomatic disorders were noted: elevation of APA; reduction in the number of platelets; growth of the ADP-induced aggregation index; extension of APTT; increase of fibrinogen, D-dimer; homocysteine. The presence of prothrombotic states associated with APS should be taken into account when preparing for IVF and perform their appropriate correction.
References
StulevaNS, Khizroeva DKh, Mashkova TIa., Abramian G.R. [Circulation of antiphospholipid antibodies and IVF failures]. Akusherstvo, ginekologija i reprodukcija. 2015; 9 (3): 6-10. Russian. doi: 10.17749/2070-4968.2015.9.3.006-010
Coughlan C, Walters S, Ledger W, Li TC. A comparison of psychological stress among women with and without reproductive failure. Int J Gynaecol Obstet. 2014; 124(2):143-7. doi: 10.1016/j.ijgo.2013.08.006.
Boivin J, Gameiro S. Evolution of psychology and counseling in infertility.Fertil Steril., 2015; 104(2):251-9. doi: 10.1016/j.fertnstert.2015.05.035.
Lai WK,KanMY. Homocysteine-Induced Endothelial Dysfunction. Ann Nutr Metab. 2015; 67(1):1-12. doi: 10.1159/000437098.
Yajnik CS, Chandak GR, Joglekar C, Katre P, Bhat DS, Singh SN, Janipalli CS, Refsum H, Krishnaveni, G, Veena S, Osmond C, Fall CH. Maternal homocysteine in pregnancy and offspring birthweight: epidemiological associations and Mendelian randomization analysis. Int J Epidemiol. 2014; 43(5):1487-97. doi: 10.1093/ije/dyu132.
Messerlian C, Gaskins AJ. Epidemiologic Approaches for Studying Assisted Reproductive Technologies: Design, Methods, Analysis and Interpretation. Curr Epidemiol Rep. 2017; 4(2):124-32. doi: 10.1007/s40471-017-0105-0.
Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F. The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med, 2017; 17 (3): 257-267. doi: https://doi.org/10.1007/s10238-016-0430-5
Sennström M, Rova K, Hellgren M, Hjertberg R, Nord E, Thurn L, Lindqvist PG. Thromboembolism and in vitro fertilization - a systematic review. Acta Obstet Gynecol Scand. 2017; 96(9):1045-52. doi: 10.1111/aogs.
Yelnik CM, Kozora E, Appenzeller S. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome. Curr Rheumatol Rep. 2016;18(2):11. doi: 10.1007/s11926-016-0568-x.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.